The “Sweet” Side of Ion Channels

Total Page:16

File Type:pdf, Size:1020Kb

The “Sweet” Side of Ion Channels Rev Physiol Biochem Pharmacol (2014) 167: 67–114 DOI: 10.1007/112_2014_20 © Springer-Verlag Berlin Heidelberg 2014 Published online: 20 September 2014 The “Sweet” Side of Ion Channels Joanna Lazniewska and Norbert Weiss Abstract Ion channels play a crucial role in cell functioning, contributing to transmembrane potential and participating in cell signalling and homeostasis. To fulfil highly specialised functions, cells have developed various mechanisms to regulate channel expression and activity at particular subcellular loci, and alteration of ion channel regulation can lead to serious disorders. Glycosylation, one of the most common forms of co- and post-translational protein modification, is rapidly emerging as a fundamental mechanism not only controlling the proper folding of nascent channels but also their subcellular localisation, gating and function. More- over, studies on various channel subtypes have revealed that glycosylation repre- sents an important determinant by which other signalling pathways modulate channel activity. The discovery of detailed mechanisms of regulation of ion chan- nels by glycosylation provides new insights in the physiology of ion channels and may allow developing new pharmaceutics for the treatment of ion channel-related disorders. Keywords Ion channel • N-linked glycosylation • O-linked glycosylation • Glycan • Protein glycosylation Contents 1 Introduction ................................................................................... 69 2 Protein Glycosylation in a Nutshell .......................................................... 70 3 Means to Investigate Glycosylation of Ion Channels ....................................... 72 3.1 Identification of N-Linked Glycosylation .................................................72 3.2 Identification of O-Linked Glycosylation .................................................73 4 Glycosylation-Dependent Regulation of Ion Channels ... .................................. 73 J. Lazniewska and N. Weiss (*) Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic e-mail: [email protected] [email protected] 68 J. Lazniewska and N. Weiss 4.1 Voltage-Gated Potassium Channels (Kv)........................................... 73 4.2 Voltage-Gated Sodium Channels (Nav)............................................. 80 4.3 Voltage-Gated Calcium Channels (Cav)............................................ 82 4.4 Hyperpolarisation-Activated Cyclic Nucleotide-Gated Channels (HCN) . 83 4.5 Transient Receptor Potential Channels (TRPs) ..................................... 84 4.6 Acid-Sensing Ion Channels (ASICs) ................................................ 88 4.7 Two-Pore Domain K+ Channels (TASK) ........................................... 89 4.8 Two-Pore Channels (TPCs) ......................................................... 90 4.9 Pannexin Channels (Panx) ........................................................... 91 4.10 CFTR Channel ....................................................................... 92 4.11 CLC Channels ........................................................................ 93 5 Crosstalk Between Glycosylation and Other Signalling Pathways ........................ 93 5.1 Regulation by Auxiliary Subunits .........................................................93 5.2 Klotho-Dependent Regulation of TRPV5 .................................................97 5.3 SP1 Induces CLC-2 Gene Expression .....................................................97 6 Modulation of Ion Channel Glycosylation by External Factors ........................... 97 6.1 Modulation by External Sugar .............................................................97 6.2 Modulation by Temperature ...............................................................98 7 Glycosylation-Mediated Channelopathy ................................................... 99 7.1 Long QT Syndrome ........................................................................99 7.2 Diabetic Neuropathic Pain .................................................................100 7.3 Cystic Fibrosis .............................................................................100 7.4 Varitint–Waddler Phenotype ..............................................................101 Conclusion and Perspectives .................................................................... 101 References ....................................................................................... 103 Abbreviations ASIC Acid-sensing ion channel B35 Neuroblastoma cell CAD Cath.a-differentiated cell Cav Voltage-gated calcium channel CDG Congenital disorders of glycosylation CFTR Cystic fibrosis transmembrane conductance regulator CHO Chinese hamster ovary cell ER Endoplasmic reticulum ERGIC ER–Golgi intermediate compartment GalNAc N-acetylgalactosamine GlcNAc-1-P N-acetylglucosamine-1-phosphate HCN Hyperpolarisation-activated cyclic nucleotide-gated channel K2P Two-pore domain potassium channel Kv Voltage-gated potassium channel LacNAc N-acetyllactosamine LQT Long QT syndrome M1 Murine cortical collecting duct Nav Voltage-gated sodium channel O-GalNAc Mucin-type O-glycan [email protected] The “Sweet” Side of Ion Channels 69 Panx Pannexin channel PNGase F Peptide-N-glycosidase F Sf9 Spodoptera frugiperda cell SKBR3 Human breast cancer cell ST3Gal4 Beta-galactoside alpha-2,3-sialyltransferase 4 ST8sia2 Alpha-2,8-sialyltransferase 2 TPC Two-pore channel TRIP8b Tetratricopeptide repeat-containing Rab8b-interacting protein TRP Transient receptor potential channel TRPC Transient receptor potential canonical channel TRPM Transient receptor potential melastatin channel TRPP Transient receptor potential polycystin channel TRPV Transient receptor potential vanilloid channel α-benzyl- 1-Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside GalNAc 1 Introduction Ion channels are pore-forming integral membrane proteins whose main function is controlling the flow of ions across cell membranes. They are multimeric protein complexes expressed both in the plasma membrane and intracellular organelles and are key contributors to the cell “well-being” (Hille 2001). It is well established that ion channels undergo chemical and post-translational modifications including acet- ylation (Shipston 2014), phosphorylation (Davis et al. 2001) (Ismailov and Benos 1995) (Levitan 1994), methylation (Baek et al. 2014) (Palmieri et al. 2012), ubiquitination (Altier et al. 2011) (Abriel and Staub 2005) (Kantamneni et al. 2011) (Marangoudakis et al. 2012) (Waithe et al. 2011), SUMOylation (Rougier et al. 2010) (Rajan et al. 2005) (Dai et al. 2009) or palmitoylation (Shipston 2011), a fundamental process controlling their expression, activity and cellular function. Recently, protein glycosylation, a process commonly known to contribute to the endoplasmic reticulum (ER) quality control of nascent polypeptide chains and critical for the proper folding, sorting and trafficking of proteins that enter the secretory pathway (Weerapana and Imperiali 2006) (Roth et al. 2010) (Moremen et al. 2012), has been also shown to play a fundamental role in modu- lating ion channel function (Ednie and Bennett 2012). Using site-directed muta- genesis of glycosylation loci, pharmacological inhibition of protein glycosylation and enzymatic removal of glycans, it was shown that preventing protein glycosyl- ation drastically alters life cycle of ion channels (Gong et al. 2002) (Mant et al. 2013) (Weiss et al. 2013) and most importantly their intrinsic activity (Jing et al. 2012) (Pertusa et al. 2012). Moreover, glycosylation at specific channel loci appears to produce variable effects on a given channel, contributing to fine-tune channel activity and fulfil highly specialised cellular functions. Interestingly enough, glycosylation of ion channels also represents a fundamental regulatory [email protected] 70 J. Lazniewska and N. Weiss platform by which various signalling pathways modulate channel activity (Leunissen et al. 2013) (Ding et al. 2014) (Laedermann et al. 2013). The network of interactions underlying glycosylation-related regulation of ion channels is grad- ually being discovered. This is of extremely high importance considering that dysregulation of ion channels gives rise to numerous human disorders, either congenital or acquired, the so-called channelopathies (Weiss and Koschak 2014) (Kim 2014), and that the list of inborn defects resulting from defective protein glycosylation (congenital disorders of glycosylation, CDG) is still growing (Scott et al. 2014). The focus of this review is to provide a comprehensive understanding of our current knowledge of the role of glycosylation in ion channel function and physiology. 2 Protein Glycosylation in a Nutshell The biochemical and enzymatic basis of protein glycosylation has recently been extensively reviewed elsewhere (Moremen et al. 2012), and thus we only provide here a succinct overview. Glycans are built from nine monosaccharides – fucose, galactose, N-acetylgalactosamine (GalNAc), glucose, N-acetylglucosamine (GlcNAc), glucuronic acid, mannose, sialic acid and xylose (Fig. 1a). Glycosylation is the enzymatic process mediated by various glycosidases and glycosyl- transferases, as opposed to glycation. Proteins can be O- and N-linked glycosylated. In the case of O-glycosylation, the oligosaccharide is attached to the protein via an oxygen atom on a serine (S) or threonine (T). In contrast, N-glycosylation involves addition of saccharides to an asparagine (N) located within a canonical
Recommended publications
  • Natural Product Modulators of Transient Receptor Potential (TRP) Channels As Potential Cite This: Chem
    Chem Soc Rev View Article Online TUTORIAL REVIEW View Journal | View Issue Natural product modulators of transient receptor potential (TRP) channels as potential Cite this: Chem. Soc. Rev., 2016, 45,6130 anti-cancer agents Tiago Rodrigues,a Florian Sieglitza and Gonçalo J. L. Bernardes*ab Treatment of cancer is a significant challenge in clinical medicine, and its research is a top priority in chemical biology and drug discovery. Consequently, there is an urgent need for identifying innovative chemotypes capable of modulating unexploited drug targets. The transient receptor potential (TRPs) channels persist scarcely explored as targets, despite intervening in a plethora of pathophysiological events in numerous diseases, including cancer. Both agonists and antagonists have proven capable of evoking phenotype changes leading to either cell death or reduced cell migration. Among these, natural products entail biologically pre-validated and privileged architectures for TRP recognition. Furthermore, several natural products have significantly contributed to our current knowledge on TRP biology. In this Creative Commons Attribution 3.0 Unported Licence. Tutorial Review we focus on selected natural products, e.g. capsaicinoids, cannabinoids and terpenes, by highlighting challenges and opportunities in their use as starting points for designing natural product- Received 17th December 2015 inspired TRP channel modulators. Importantly, the de-orphanization of natural products as TRP channel DOI: 10.1039/c5cs00916b ligands may leverage their exploration as viable strategy for developing anticancer therapies. Finally, we foresee that TRP channels may be explored for the selective pharmacodelivery of cytotoxic payloads to www.rsc.org/chemsocrev diseased tissues, providing an innovative platform in chemical biology and molecular medicine.
    [Show full text]
  • The Intracellular Ca2+ Release Channel TRPML1 Regulates Lower Urinary Tract Smooth Muscle Contractility
    The intracellular Ca2+ release channel TRPML1 regulates lower urinary tract smooth muscle contractility Caoimhin S. Griffina, Michael G. Alvaradoa, Evan Yamasakia, Bernard T. Drummb,c, Vivek Krishnana, Sher Alia, Eleanor M. Naglea, Kenton M. Sandersb, and Scott Earleya,1 aDepartment of Pharmacology, Center for Molecular and Cellular Signaling in the Cardiovascular System, Reno School of Medicine, University of Nevada, Reno, NV 89557-0318; bDepartment of Physiology and Cell Biology, Reno School of Medicine, University of Nevada, Reno, NV 89557-0318; and cDepartment of Life & Health Sciences, Dundalk Institute of Technology, Louth, Ireland A91 K584 Edited by Mark T. Nelson, University of Vermont, Burlington, VT, and approved October 13, 2020 (received for review August 12, 2020) TRPML1 (transient receptor potential mucolipin 1) is a Ca2+-perme- including dense granulomembranous storage bodies in neurons, able, nonselective cation channel that is predominantly localized to elevated plasma gastrin, vacuolization in the gastric mucosa, and the membranes of late endosomes and lysosomes (LELs). Intracellular retinal degeneration (14). Interestingly, however, an anatomical release of Ca2+ through TRPML1 is thought to be pivotal for mainte- examination of these mice reveals dramatically distended bladders nance of intravesicular acidic pH as well as the maturation, fusion, and (14), leading us to question how TRPML1, an intracellular Ca2+- trafficking of LELs. Interestingly, genetic ablation of TRPML1 in mice release channel important in LEL function, affects bladder −/− (Mcoln1 ) induces a hyperdistended/hypertrophic bladder phenotype. physiology. Here, we investigated this phenomenon further by exploring an un- The lower urinary tract (LUT) is composed of the urinary conventional role for TRPML1 channels in the regulation of Ca2+-signal- bladder and urethra—structures that serve the simple, reciprocal ing activity and contractility in bladder and urethral smooth muscle cells functions of storing and voiding urine (15).
    [Show full text]
  • Recessive Mutations of the Gene TRPM1 Abrogate on Bipolar Cell Function and Cause Complete Congenital Stationary Night Blindness in Humans
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT Recessive Mutations of the Gene TRPM1 Abrogate ON Bipolar Cell Function and Cause Complete Congenital Stationary Night Blindness in Humans Zheng Li,1 Panagiotis I. Sergouniotis,1 Michel Michaelides,1,2 Donna S. Mackay,1 Genevieve A. Wright,2 Sophie Devery,2 Anthony T. Moore,1,2 Graham E. Holder,1,2 Anthony G. Robson,1,2 and Andrew R. Webster1,2,* Complete congenital stationary night blindness (cCSNB) is associated with loss of function of rod and cone ON bipolar cells in the mammalian retina. In humans, mutations in NYX and GRM6 have been shown to cause the condition. Through the analysis of a consan- guineous family and screening of nine additional pedigrees, we have identified three families with recessive mutations in the gene TRPM1 encoding transient receptor potential cation channel, subfamily M, member 1, also known as melastatin. A number of other variants of unknown significance were found. All patients had myopia, reduced central vision, nystagmus, and electroretinographic evidence of ON bipolar cell dysfunction. None had abnormalities of skin pigmentation, although other skin conditions were reported. RNA derived from human retina and skin was analyzed and alternate 50 exons were determined. The most 50 exon is likely to harbor an initiation codon, and the protein sequence is highly conserved across vertebrate species. These findings suggest an important role of this specific cation channel for the normal function of ON bipolar cells in the human retina. Congenital stationary night blindness (CSNB) is a group of of the gene encoding transient receptor potential cation genetically determined, nondegenerative disorders of the channel, subfamily M, member 1 (TRPM1 [MIM *603576]) retina associated with lifelong deficient vision in the dark has been discovered in the skin and retina of horses homo- and often nystagmus and myopia.
    [Show full text]
  • TRPC1 Antibody Affinity Purified Polyclonal Antibody Catalog # AG1458
    9765 Clairemont Mesa Blvd, Suite C San Diego, CA 92124 Tel: 858.875.1900 Fax: 858.622.0609 TRPC1 Antibody Affinity purified polyclonal antibody Catalog # AG1458 Specification TRPC1 Antibody - Product Information Application WB, IHC Primary Accession P48995 Reactivity Human, Mouse, Rat Host Rabbit Clonality Polyclonal Calculated MW 91212 Homology Mouse, rat, human - identical; rabbit, bovine - 14/15 amino acid residues identical; Western blot analysis of rat brain Xenopus Laevis - membranes: 11/14 amino acid 1. Anti-TRPC1 antibody (#AG1458), (1:200). residues identical. 2. Anti-TRPC1 antibody, preincubated with the control peptide antigen. TRPC1 Antibody - Additional Information Gene ID 7220 Other Names Short transient receptor potential channel 1, TrpC1, Transient receptor protein 1, TRP-1, TRPC1, TRP1 Related products for control experiments Control peptide antigen (supplied with the antibody free of charge). Target/Specificity Peptide QLYDKGYTSKEQKDC, corresponding to amino acid residues 557-571 of human .TRPC1 (Accession P48995).ֲ ֲ Intracellular Expression of TRPC1 in mouse cerebellum Immunohistochemical staining of mouse Dilution WB~~1:200-1:2000 cerebellum frozen sections using Anti-TRPC1 antibody (#AG1458). A. TRPC1 (red) appears in Peptide Confirmation Purkinje cells (arrows) and in the molecular Confirmed by amino acid analysis and (Mol) and granule (Gran) layers. B. Staining massspectrography. with mouse anti-parvalbumin (PV) in the same brain section. C. Confocal merge of TRPC1 and Application Details PV demonstrates partial co-localization in the Western blot analysis (WB): - Mouse brain Purkinje and the molecular layers. lysate (see Feng, S. <em>et al.</em> (2013) in Product Citations). - Rat distal pulmonary smooth muscle cell lysate (PASMCs), (see TRPC1 Antibody - Background Zhang, Y.
    [Show full text]
  • Endolysosomal Cation Channels As Therapeutic Targets—Pharmacology of TRPML Channels
    Review Copyright © 2016 American Scientific Publishers MESSENGER Vol. 5, 30–36, 2016 All rights reserved www.aspbs.com/messenger Printed in the United States of America Endolysosomal Cation Channels as Therapeutic Targets—Pharmacology of TRPML Channels Christian Grimm Munich Center for Integrated Protein Science CIPSM and Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, 81377, Germany In recent years it has become more and more accepted that the endolysosomal system (ES) plays a key role for human health. Dysfunction of the ES has been found to be implicated in a range of human diseases ranging MESSENGER from infectious and metabolic to lysosomal storage, retinal and neurodegenerative diseases. Results obtained from animal models and human mutations have also spurred the interest in endolysosomal membrane proteins. In particular, the study of endolysosomal ion channels as potential novel drug targets for the treatment of various diseases has gained momentum with recently established endolysosomal patch-clamp techniques. These tech- niques now allow functional characterization of these organellar membrane proteins in more detail. Another key development was the discovery of small molecule agonists and antagonists to pharmacologically interfere with these endolysosomal ion channels in vitro and in vivo. This review gives an overview of the currently available small molecule agonists and antagonists of one major group of endolysosomal cation channels, the mucolipins or TRPML channels and how they have helped to speed up research in the field. Keywords: Calcium, TRPML, MCOLN, TRPML1, Mucolipin. MESSENGER MESSENGER IP: 192.168.39.151 On: Thu, 30 Sep 2021 22:36:36 Copyright: American Scientific Publishers CONTENTS Delivered byand Ingenta neurodegenerative diseases, retinal and pigmentation disorders, trace metal dishomeostasis and infectious dis- Introduction ............................................30 eases (Fig.
    [Show full text]
  • Heteromeric TRP Channels in Lung Inflammation
    cells Review Heteromeric TRP Channels in Lung Inflammation Meryam Zergane 1, Wolfgang M. Kuebler 1,2,3,4,5,* and Laura Michalick 1,2 1 Institute of Physiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; [email protected] (M.Z.); [email protected] (L.M.) 2 German Centre for Cardiovascular Research (DZHK), 10785 Berlin, Germany 3 German Center for Lung Research (DZL), 35392 Gießen, Germany 4 The Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON M5B 1W8, Canada 5 Department of Surgery and Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada * Correspondence: [email protected] Abstract: Activation of Transient Receptor Potential (TRP) channels can disrupt endothelial bar- rier function, as their mediated Ca2+ influx activates the CaM (calmodulin)/MLCK (myosin light chain kinase)-signaling pathway, and thereby rearranges the cytoskeleton, increases endothelial permeability and thus can facilitate activation of inflammatory cells and formation of pulmonary edema. Interestingly, TRP channel subunits can build heterotetramers, whereas heteromeric TRPC1/4, TRPC3/6 and TRPV1/4 are expressed in the lung endothelium and could be targeted as a protec- tive strategy to reduce endothelial permeability in pulmonary inflammation. An update on TRP heteromers and their role in lung inflammation will be provided with this review. Keywords: heteromeric TRP assemblies; pulmonary inflammation; endothelial permeability; TRPC3/6; TRPV1/4; TRPC1/4 Citation: Zergane, M.; Kuebler, W.M.; Michalick, L. Heteromeric TRP Channels in Lung Inflammation. Cells 1. Introduction 2021, 10, 1654. https://doi.org Pulmonary microvascular endothelial cells are a key constituent of the blood air bar- /10.3390/cells10071654 rier that has to be extremely thin (<1 µm) to allow for rapid and efficient alveolo-capillary gas exchange.
    [Show full text]
  • Download File
    STRUCTURAL AND FUNCTIONAL STUDIES OF TRPML1 AND TRPP2 Nicole Marie Benvin Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2017 © 2017 Nicole Marie Benvin All Rights Reserved ABSTRACT Structural and Functional Studies of TRPML1 and TRPP2 Nicole Marie Benvin In recent years, the determination of several high-resolution structures of transient receptor potential (TRP) channels has led to significant progress within this field. The primary focus of this dissertation is to elucidate the structural characterization of TRPML1 and TRPP2. Mutations in TRPML1 cause mucolipidosis type IV (MLIV), a rare neurodegenerative lysosomal storage disorder. We determined the first high-resolution crystal structures of the human TRPML1 I-II linker domain using X-ray crystallography at pH 4.5, pH 6.0, and pH 7.5. These structures revealed a tetramer with a highly electronegative central pore which plays a role in the dual Ca2+/pH regulation of TRPML1. Notably, these physiologically relevant structures of the I-II linker domain harbor three MLIV-causing mutations. Our findings suggest that these pathogenic mutations destabilize not only the tetrameric structure of the I-II linker, but also the overall architecture of full-length TRPML1. In addition, TRPML1 proteins containing MLIV- causing mutations mislocalized in the cell when imaged by confocal fluorescence microscopy. Mutations in TRPP2 cause autosomal dominant polycystic kidney disease (ADPKD). Since novel technological advances in single-particle cryo-electron microscopy have now enabled the determination of high-resolution membrane protein structures, we set out to solve the structure of TRPP2 using this technique.
    [Show full text]
  • Trpml-Mediated Astrocyte Microdomain Ca2+ Transients Regulate Astrocyte– Tracheal Interactions Zhiguo Ma*, Marc R Freeman*
    RESEARCH ARTICLE TrpML-mediated astrocyte microdomain Ca2+ transients regulate astrocyte– tracheal interactions Zhiguo Ma*, Marc R Freeman* Vollum Institute, Oregon Health and Science University, Portland, United States Abstract Astrocytes exhibit spatially-restricted near-membrane microdomain Ca2+transients in their fine processes. How these transients are generated and regulate brain function in vivo remains unclear. Here we show that Drosophila astrocytes exhibit spontaneous, activity- independent microdomain Ca2+ transients in their fine processes. Astrocyte microdomain Ca2+ transients are mediated by the TRP channel TrpML, stimulated by reactive oxygen species (ROS), and can be enhanced in frequency by the neurotransmitter tyramine via the TyrRII receptor. Interestingly, many astrocyte microdomain Ca2+ transients are closely associated with tracheal elements, which dynamically extend filopodia throughout the central nervous system (CNS) to 2+ deliver O2 and regulate gas exchange. Many astrocyte microdomain Ca transients are spatio- temporally correlated with the initiation of tracheal filopodial retraction. Loss of TrpML leads to increased tracheal filopodial numbers, growth, and increased CNS ROS. We propose that local ROS production can activate astrocyte microdomain Ca2+ transients through TrpML, and that a subset of these microdomain transients promotes tracheal filopodial retraction and in turn modulate CNS gas exchange. Introduction *For correspondence: 2+ [email protected] (ZM); Astrocytes exhibit two major types of Ca signaling events, whole-cell fluctuations and near-mem- 2+ [email protected] (MRF) brane microdomain Ca transients (Khakh and McCarthy, 2015). Whole-cell transients are coordi- nated across astrocyte networks and regulated by adrenergic receptor signaling. Emerging data Competing interests: The suggests these transients are important for state-dependent changes (Ding et al., 2013; Ma et al., authors declare that no 2016; Paukert et al., 2014; Srinivasan et al., 2015), and involve TRPA1 channels that regulate the competing interests exist.
    [Show full text]
  • Transient Receptor Potential Canonical (TRPC) Channels As Modulators of Migration and Invasion
    International Journal of Molecular Sciences Review Transient Receptor Potential Canonical (TRPC) Channels as Modulators of Migration and Invasion Muhammad Yasir Asghar 1,2 and Kid Törnquist 1,2,* 1 Minerva Foundation Institute for Medical Research, Biomedicum Helsinki 2U, Tukholmankatu 8, 00290 Helsinki, Finland; yasir.asghar@helsinki.fi 2 Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Tykistökatu 6A, 20520 Turku, Finland * Correspondence: ktornqvi@abo.fi Received: 11 February 2020; Accepted: 26 February 2020; Published: 3 March 2020 Abstract: Calcium (Ca2+) is perhaps the most versatile signaling molecule in cells. Ca2+ regulates a large number of key events in cells, ranging from gene transcription, motility, and contraction, to energy production and channel gating. To accomplish all these different functions, a multitude of channels, pumps, and transporters are necessary. A group of channels participating in these processes is the transient receptor potential (TRP) family of cation channels. These channels are divided into 29 subfamilies, and are differentially expressed in man, rodents, worms, and flies. One of these subfamilies is the transient receptor potential canonical (TRPC) family of channels. This ion channel family comprises of seven isoforms, labeled TRPC1–7. In man, six functional forms are expressed (TRPC1, TRPC3–7), whereas TRPC2 is a pseudogene; thus, not functionally expressed. In this review, we will describe the importance of the TRPC channels and their interacting molecular partners in the etiology of cancer, particularly in regard to regulating migration and invasion. Keywords: TRPC; ion channels; cancer; thyroid; calcium; migration; invasion; angiogenesis 1. Introduction Increasing evidence during the past decade indicates that different ion channels are expressed in several cancers in humans, and regulate a multitude of cellular processes, including migration, invasion and proliferation [1–3].
    [Show full text]
  • A Novel Role for Polycystin-2 (Pkd2) in P. Tetraurelia As a Probable Mg2+ Channel Necessary for Mg2+- Induced Behavior
    Article A Novel Role for Polycystin-2 (Pkd2) in P. tetraurelia as a Probable Mg2+ Channel Necessary for Mg2+- Induced Behavior Megan S. Valentine 1,*, Junji Yano 2 and Judith Van Houten 2 1 State University of New York at Plattsburgh, 101 Broad Street, Plattsburgh, NY 12901, USA 2 University of Vermont, Department of Biology, 120 Marsh Life Science, 109 Carrigan Drive, Burlington, VT 05405, USA; [email protected] (J.Y.); [email protected] (J.V.H.) * Correspondence: [email protected]; 518-564-4116 Received: 11 April 2019; Accepted: 11 June 2019; Published: 14 June 2019 Abstract: A human ciliopathy gene codes for Polycystin-2 (Pkd2), a non-selective cation channel. Here, the Pkd2 channel was explored in the ciliate Paramecium tetraurelia using combinations of RNA interference, over-expression, and epitope-tagging, in a search for function and novel interacting partners. Upon depletion of Pkd2, cells exhibited a phenotype similar to eccentric (XntA1), a Paramecium mutant lacking the inward Ca2+-dependent Mg2+ conductance. Further investigation showed both Pkd2 and XntA localize to the cilia and cell membrane, but do not require one another for trafficking. The XntA-myc protein co-immunoprecipitates Pkd2-FLAG, but not vice versa, suggesting two populations of Pkd2-FLAG, one of which interacts with XntA. Electrophysiology data showed that depletion and over-expression of Pkd2 led to smaller and larger depolarizations in Mg2+ solutions, respectively. Over-expression of Pkd2-FLAG in the XntA1 mutant caused slower swimming, supporting an increase in Mg2+ permeability, in agreement with the electrophysiology data. We propose that Pkd2 in P.
    [Show full text]
  • Organellar TRP Channels
    REVIEW ARTICLE https://doi.org/10.1038/s41594-018-0148-z Organellar TRP channels Xiaoli Zhang1,3, Meiqin Hu1,2,3, Yexin Yang1 and Haoxing Xu 1* Mammalian transient receptor potential (TRP) channels mediate Ca2+ flux and voltage changes across membranes in response to environmental and cellular signals. At the plasma membrane, sensory TRPs act as neuronal detectors of physical and chemi- cal environmental signals, and receptor-operated (metabotropic) TRPs decode extracellular neuroendocrine cues to control body homeostasis. In intracellular membranes, such as those in lysosomes, organellar TRPs respond to compartment-derived signals to control membrane trafficking, signal transduction, and organelle function. Complementing mouse and human genet- ics and high-resolution structural approaches, physiological studies employing natural agonists and synthetic inhibitors have become critical in resolving the in vivo functions of metabotropic, sensory, and organellar TRPs. RP was initially identified as a receptor-operated sensory In this review, we summarize our current knowledge of TRP cation channel required for sustained light responses in channels, focusing in particular on the least-known functional Drosophila1–3. Subsequent homology cloning revealed a super- group, the organellar TRPs, to bring together findings from stud- T 4–8 family of cation channels in mammals . On the basis of sequence ies on channel modulation, atomic structures, cell biology, animal homology, mammalian TRPs can be divided into six subfamilies: physiology, and disease. TRPC1–TRPC7 (C for canonical), TRPV1–TRPV6 (V for vanil- loid), TRPM1–TRPM8 (M for melastatin), TRPA1 (A for Ankyrin), Physiology and architecture of TRP channels TRPML1–TRPML3 (ML for mucolipin), and TRPP1–TRPP3 TRPs are Ca2+-flux channels that can be activated by both physical (P for polycystin) (Table 1).
    [Show full text]
  • Mammalian TRP Ion Channels Are Insensitive to Membrane Stretch Yury A
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs238360. doi:10.1242/jcs.238360 RESEARCH ARTICLE Mammalian TRP ion channels are insensitive to membrane stretch Yury A. Nikolaev1,2,*, Charles D. Cox1, Pietro Ridone1, Paul R. Rohde1, Julio F. Cordero-Morales3, Valeria Vásquez3, Derek R. Laver2,‡ and Boris Martinac1,4,‡ ABSTRACT channels play a significant role in sensory physiology, with most of 2+ TRP channels of the transient receptor potential ion channel them contributing to cellular Ca signaling and homoeostasis. All superfamily are involved in a wide variety of mechanosensory TRP channels are polymodally regulated and involved in various processes, including touch sensation, pain, blood pressure sensations in humans, including taste, temperature, pain, pressure and regulation, bone loading and detection of cerebrospinal fluid flow. vision (Vriens et al., 2014; Julius, 2013). Multiple studies have However, in many instances it is unclear whether TRP channels are demonstrated TRP channel involvement in mechanosensory the primary transducers of mechanical force in these processes. In transduction in mammals (Spassova et al., 2006; Wilson and Dryer, this study, we tested stretch activation of eleven TRP channels from 2014; Spassova et al., 2004; Welsh et al., 2002; Quick et al., 2012), six mammalian subfamilies. We found that these TRP channels were including most notably TRPA1 (Corey et al., 2004), TRPV4 (Loukin insensitive to short membrane stretches in cellular systems. et al., 2010), TRPV2 (Muraki et al., 2003; Katanosaka et al., 2014), Furthermore, we purified TRPC6 and demonstrated its PKD2 (Narayanan et al., 2013), PKD2L1 (Sternberg et al., 2018), insensitivity to stretch in liposomes, an artificial bilayer system free TRPC3 and TRPC6 (Nikolova-Krstevski et al., 2017; Quick et al., from cellular components.
    [Show full text]